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PURPOSE. For more than 20 years, there has been an international, multidisciplinary effort to
develop retinal prostheses to restore functional vision to patients blinded by retinal
degeneration. We developed a novel subretinal prosthesis with 1512 optically addressed
silicon nanowire photodiodes, which transduce incident light into an electrical stimulation of
the remaining retinal circuitry. This study was conducted to evaluate the efficacy of optically
driving the subretinal prosthesis to produce visual cortex activation via electrical stimulation
of the retina.
METHODS. We measured electrically evoked potential responses (EEPs) in rabbit visual cortex
in response to illumination of the subretinal nanowire prosthesis with pulsed 852-nm infrared
(IR) light. We compared the EEP responses to visually evoked potential responses (VEPs) to
pulsed 532-nm visible light (positive control) and pulsed 852-nm IR light (negative control).
RESULTS. Activating the devices with IR light produced EEP responses with a significantly
higher trough-to-peak amplitude (54.17 6 33.4 lV) than IR light alone (24.07 6 22.1 lV) or
background cortical activity (23.22 6 17.2 lV). EEP latencies were significantly faster than
focal VEP latencies. Focal VEPs produced significantly higher amplitudes (94.88 6 43.3 lV)
than EEPs. We also demonstrated how an electrode placed on the cornea can be used as a
noninvasive method to monitor the function of the implant.
CONCLUSIONS. These results show that subretinal electrical stimulation with nanowire
electrodes can elicit EEPs in the visual cortex, providing evidence for the viability of a
subretinal nanowire prosthetic approach for vision restoration.
Keywords: retinal prosthesis, implant, nanowires, in vivo, rabbit
Retinitis pigmentosa and AMD are debilitating causes ofblindness resulting from the gradual loss of photoreceptors
in the outer retina. It is estimated that more than one million
people worldwide are blinded by retinitis pigmentosa,1 and it is
projected that there will be 196 million people with AMD by
2020.2 Available treatments slow the progress of the degener-
ation but do not reverse vision loss. In these diseases, only the
photoreceptor layer degenerates, leaving the remainder of the
retina intact,3 albeit with some remodeling.4 Retinal prosthetics
function by electrically stimulating spared retina, bypassing the
missing photosensory neurons. This approach makes use of the
remaining visual pathway to elicit phosphenes in a retinotopic
manner to restore some useful vision to the patient.
There are three retinal prostheses that are available to
patients in the European Economic Area having been granted
the CE mark for commercial use: Retina Implant Alpha AMS
subretinal implant with 1600 electrodes at 70-lm pitch (Retina
Implant AG, Reutlingen, Germany),5,6 IRIS II epiretinal implant
with 150 electrodes (Pixium Vision, Paris, France),7 and Argus
II epiretinal implant (Second Sight Medical Products, Inc.,
Sylmar, CA, USA).8 Of those, only the Argus II device is also
approved by the US Food and Drug Administration (FDA) and
available to patients in the US market, but its 60 electrodes at
525-lm electrode pitch results in stimulation being spread over
a large field of view, precluding high-resolution vision. Recently,
Retina Implant AG and Pixium Vision have commenced clinical
trials in the United States for their latest devices, Alpha AMS9
and PRIMA10 (378 photovoltaic electrodes, 70-lm pitch).11–16 A
major goal of retinal prosthetic development is to decrease
pixel spacing and increase pixel number to improve high acuity
vision over a larger area of the visual field.
We developed a retinal prosthesis with a high-resolution
subretinal neurostimulator consisting of 1512 optically ad-
dressed silicon nanowire photodiodes.17 Each nanowire
photodiode converts incident light into electric current to
stimulate nearby inner retinal neurons, which allows for a
compact, optically addressable stimulating array and obviates
the need for individually wired electrodes. There are several
key advantages to implanting the device in the subretinal space.
Specifically, it avoids direct activation of retinal ganglion cell
axons in the retinal fiber layer, which can cause streaked
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phosphenes.18 It also makes use of remaining inner retinal
circuitry, allowing for more natural image processing.
In vivo electrophysiology studies are essential to demon-
strate that an implant effectively stimulates the retina to
generate neural signals that are transmitted to the visual cortex
as in natural vision. Recording visually evoked potentials
(VEPs) from the occipital cortex in response to repeated visual
stimuli is a common clinical measure of visual pathway
integrity.19 This technique can be extended to record
electrically evoked potentials (EEPs) to demonstrate the
effectiveness of prosthetics to electrically stimulate the retina
and cause a cortical response in the visual cortex.20–31 In vivo
studies also allow for optimization of surgical technique and
biocompatibility evaluation of the retinal prosthetic device in
an animal model. Here, we use an in vivo rabbit model to
demonstrate the effectiveness of subretinal stimulation with a
nanowire prosthesis and compare the visible light–induced
VEP response with the EEP response to prosthetic stimulation.
METHODS
Photovoltaic Implants
The silicon nanowire photovoltaic devices were fabricated
using the procedures as previously described.17 The subretinal
implants consisted of six silicon tiles mounted onto a flexible
polyimide substrate (Fig. 1, bottom right), covering an area of 3
3 4 mm, or approximately 178 of visual field. Each tile
measured 1.4 3 0.5 mm and contained an array of 252
sputtered iridium oxide film (SIROF) electrodes with a
diameter of 12 lm and spaced with a pitch of 50 lm (Fig. 1,
bottom left) for a total of 1512 stimulating electrodes. Each
electrode consisted of a group of 85 vertically aligned silicon p-
n junction nanowires (Fig. 1, top), bundled together under a
transparent indium tin oxide electrode. Through the photo-
voltaic effect, the nanowires convert the energy of the incident
light into an electron-hole electrical charge pair, as a typical
photodiode.32–35 Each nanowire electrode pixel is coated with
parylene and capped with a SIROF electrode located in the
center of the pixel, which delivers the charge to the retina. The
stimulating electrodes shared a common return electrode
located 6 mm away from the stimulating electrodes. In this
study, the devices were unbiased and powered only with high-
intensity infrared (IR) light described later. Each implant was
sterilized in a steam autoclave (Tuttnauer, Hauppauge, NY,
USA) for 7 minutes at 31 PSI and 1348C.
Device Implantation Surgery
New Zealand pigmented rabbits (N ¼ 12; average age, 4.9
months; 4.1 kg) were implanted with a subretinal prosthesis in
this study. All experimental methods and animal care
procedures adhered to the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research and were
approved by the University of California, San Diego, Institu-
tional Animal Care and Use Committee. Anesthesia was
induced by a cocktail of ketamine hydrochloride (35 mg/kg)
and xylazine (5 mg/kg) administered by subcutaneous injec-
tion and maintained with alternating half-doses of ketamine
only or ketamine and xylazine every 30 to 40 minutes. The
pupils were dilated with 1% atropine, 0.5% tropicamide, and
2.5% phenylephrine. Implantation of the device was performed
using a trans-scleral (i.e., ab externo) approach unilaterally in
the right eye. Two polyimide glides were used to support the
device on both sides as it was inserted into the subretinal
space. The head of the device containing the stimulating
electrode array was placed near the visual streak. The tail of
the implant was anchored at the scleral incision by a 7-0 nylon
suture. After insertion, a 25-gauge three-port trans pars plana
vitrectomy was performed before air–fluid exchange and final
tamponade with silicon oil (ADATO SIL-ol 5000; Bausch &
Lomb, Rochester, NY, USA). The vitrectomy was performed
using a Landers wide field vitrectomy lens under a surgical
microscope (Zeiss, Oberkochen, Germany). Fundus photo-
graphs (Fig. 2) and optical coherence tomography (OCT; Fig.
3) were taken the following day to verify implant position.
Cortical Electrode Implantation Surgery
The day following implantation surgery, the rabbit was
implanted with cortical recording electrodes as previously
described.27,36 The rabbit was anesthetized as described above,
FIGURE 1. The retinal prosthesis consists of six tiles on a polyimide
substrate (bottom right). Each tile has 252 electrodes (bottom left).
Each of the electrodes has 85 silicon nanowires capped with iridium
oxide (top).
FIGURE 2. Fundus photograph showing retina covering the six-tiled
nanowire implant following surgical placement into the subretinal
space.
In Vivo Performance of Nanowire Retinal Prosthesis IOVS j December 2018 j Vol. 59 j No. 15 j 5886
and the skin over the posterior skull was prepared by shaving
the scalp with electric clippers. The skin was incised, the
periosteum was opened, and the skull was exposed. Two skull
burr holes were made with a 1.5-mm surgical drill 5 mm away
from the sagittal suture on each side overlying the visual cortex
and 6 mm anterior to lambda. A third burr hole was made for
the reference electrode 3 mm right of the sagittal suture and 5
mm anterior to bregma (Fig. 4). A grounding electrode was
placed on the ear. Subsequently, 4.75-mm cranial screw
electrodes were inserted until achieving contact with the
dura. Dental cement was then applied and cured to hold the
electrodes securely in place and the incision was closed by
suturing.
Light Stimulation Delivery
A Large Spot slit-lamp adapter (Iridex Corp., Mountain View,
CA, USA) was used to project a 3-mm-diameter laser through a
slit-lamp (Haag-Streit, Mason, OH, USA) into the eye. Two laser
diodes (DJ532-40 and L852P150; Thorlabs, Newton, NJ, USA)
were used to emit 10-ms pulses every 500 ms of either 532-nm
100-lW/mm2 green light or 852-nm 3.4-mW/mm2 infrared
light. Green 532-nm light was used as a positive control to
verify natural VEPs were elicited from retina over the implant.
Although the device is sensitive to both visible and IR light, we
used 852-nm IR light to activate the device to avoid natural
stimulation of the rabbit photoreceptors. The laser diodes were
mounted in a temperature-controlled mount (TCLDM9; Thor-
labs) and driven by a Benchtop Laser Controller (ITC4020;
Thorlabs). In patients, a glasses-mounted camera will capture
the visual scene and project patterns of IR light into the
implanted eye via a DLP pico display (Texas Instruments,
Dallas, TX, USA) while still permitting visible light to pass
through allowing for residual natural vision.
Electrophysiology Recording
Electrophysiology measurements were recorded using an
animal physiology UBA-4204 Universal Biomedical Amplifier
(LKC Technologies, Gaithersburg, MD, USA) at 2-kHz sampling
rate. A low-cut filter at 1 Hz, high-cut filter at 100 Hz, and notch
filter at 60 Hz were applied to reduce ambient electrical noise.
Unrelated cortical activity and noise were further minimized by
averaging trial repeats (50 to 200) for each experimental
condition. A HK Loop ERG electrode (Unimed Electrode
Supplies, Farnham, UK) was placed on the cornea to monitor
the device electrical activation, and a reference electrode was
placed on the nose. Data were recorded for 256 ms every 500
ms. Following electrophysiology recordings, anesthetized
animals were euthanized by an intracardiac injection of 120
mg sodium pentobarbital/kg body weight. After euthanasia, the
eyes were enucleated and processed for histologic analysis by
light microscopy.
Data Analysis
Data were imported into MATLAB (The Mathworks, Inc.,
Natick, MA, USA) for visualization and analysis. The baseline,
measured at the first point, was subtracted from each trace
such that all recordings began at 0 V. The amplitude of the N1
was measured at the lowest local minimum between time 20
and 60 ms after the start of the laser pulse. The start of the N1
time window was set at 20 ms to exclude the stimulation
artifact. We used 60 ms as the end of the N1 time window
based on the existing literature and preliminary data. P2 was
FIGURE 3. OCT imaging 24 hours after implantation shows that retina
overlaying the device is in close contact with the retinal prosthesis
tiles. The horizontal line across the prosthesis (A) corresponds to the
cross section of retina over the tiles shown below (B).
FIGURE 4. Cortical screw electrode placement diagram demonstrating
electrode locations with respect to skull suture landmarks in the rabbit.
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measured at the highest local maximum between 60 ms and
the end of the recording. Local extrema were determined with
the findpeaks MATLAB function. The VEP and EEP amplitudes
were calculated from N1 trough to P2 peak. Latency of N1 and
P2 was calculated from the start of the onset of the laser pulse.
A total of 229 cortical recordings were made from seven
rabbits (14 eyes): 108 recordings (from 7 eyes) of IR laser on
the device-inducing EEPs, 45 recordings (from 7 eyes) of focal
green laser–inducing VEPs in the implanted eye, 54 (from 7
eyes) recordings of baseline cortical activity without stimula-
tion, and 22 (from 4 eyes) recordings of IR laser stimulation in
the nonimplanted eye. Corneal potentials were recorded from
six rabbits.
For the statistical analysis, a mixed model regression was
performed using the VEP and EEP amplitudes as the dependent
variable and recording conditions (four groups) as the
independent variable while assigning the animal ID as a
random effect to account for the repeated measurements. After
identification of a significant association between amplitude
and recording conditions, further comparisons of the least
square means of amplitude among the four recording
conditions were performed using the Student t-test while
limiting type I errors to a rate of 0.05. The statistical analysis
was performed using JMP SAS software version 13 (JMP, Cary,
NC, USA).
RESULTS
EEPs
To examine how stimulation of the prosthetic device activates
retina, EEPs were recorded by activating the subretinal
prosthesis with a 10-ms pulse, 3-mm-diameter spot size, and
852-nm IR laser with an intensity of 3.4 mW/mm2, resulting in
a charge injection of 0.32 nC per electrode; 852-nm light
activates the prosthesis with high efficiency but does not
activate mammalian photoreceptors.37 IR stimulation of the
device resulted in a voltage waveform on the contralateral
electrode with a negative peak (N1) after stimulation followed
by a positive peak (P2), consistent with activation of the visual
cortex (Fig. 5). The average EEP amplitude from 108 recordings
was 54.17 lV (SD¼33.4) and average N1 latency was 36.55 ms
(SD ¼ 11.6; Table; Fig. 6).
To determine whether high intensity IR light could directly
activate photoreceptors and cause a VEP without prosthetic
stimulation, we pulsed 852-nm light in the nonimplanted eye at
the same intensity and duration. The nonimplanted eye was
used instead of focusing the laser spot on retina away from the
device to eliminate the possibility of activating the device with
scattered light from the high-powered laser. No VEP waveform
was observed from IR stimulation in nonimplanted eyes, and
the average trough-to-peak amplitude of cortical activity in
response to pulsed IR light stimulation was not significantly
different from baseline cortical activity recordings in the
absence of any stimulation (Fig. 6).
Focal VEPs Elicited From Retina Over the Device
To examine how implantation of the prosthetic device may
influence normal responses of the retina, we stimulated the
implanted eye with a visual stimulus using a 3-mm-diameter
spot of 532-nm laser pulsed for 10 ms at 2 Hz. From a total of
45 recordings, the average focal VEP amplitude was 94.88 6
43.3 lV (SD) and average N1 latency was 48.04 6 12.3 ms
(SD). Implanted eyes remained sensitive to visible light after
implantation, exhibiting normal VEP waveform kinetics. The
VEP amplitudes were greater than EEP amplitudes (P <
0.0001), and EEP N1 latencies were significantly faster than
VEP N1 latencies by an average of 11.5 ms (P < 0.0001).
FIGURE 5. Example EEPs from four rabbits in response to electrical stimulation of the retina as the subretinal implant was activated with a 10-ms
pulse of IR light over 50 repeats averaged. EEP N1 and P2 are marked with arrows (). Example VEPs in response to focal green stimulation are
shown for comparison. VEP N1 and P2 are marked with asterisks (*). No VEPs were detected in response to 10-ms pulsed IR light in the
nonimplanted eye, which resulted in a signal similar to baseline cortical activity without stimulation.
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Noninvasive Device Performance Monitoring
The HK Loop ERG electrode placed on the cornea was used to
record the voltage change as the device was activated with
varying light intensities. These measurements were recorded in
three rabbits before euthanasia and three rabbits immediately
after euthanasia; no systematic difference was observed
between before and after euthanasia experiments. A typical
device activation signal is shown in the top graph of Figure 7 as
IR light was pulsed for 10 ms while varying the IR power from
0 to 3.4 mW/mm2. The trough-to-peak corneal potential
amplitudes resulting from device activation increases logarith-
mically with increased IR laser power, as shown in the bottom
six graphs of Figure 7. Although the corneal potential
amplitude varied greatly between recordings, the shape of
the relationship between corneal potential and irradiance
remained consistent.
DISCUSSION
The purpose of this study was to determine the feasibility of a
photovoltaic nanowire–based subretinal prosthesis to drive
visual responses in a rabbit model. We demonstrate that the
subretinal nanowire prosthesis can generate visual cortical
signals powered only with infrared light by recording EEPs in
anesthetized rabbit visual cortex. Furthermore, as a negative
control, we showed that IR light of the same intensity does not
cause any stimulation of photoreceptors in intact retina of the
nonimplanted eye, indicating that visual cortical signals are the
result of electrical stimulation of the retina by the prosthetic.
Initially the negative control recordings were taken by focusing
the IR laser on retina further away from the device in the
implanted eye; however, we detected some device activation
from the corneal electrode recording, likely due to scattering
light from the high intensity laser. Therefore, the nonimplanted
eye was used to prevent scattered light from confounding the
experiment. In addition, we demonstrate that subretinal
implantation of the prosthetic device can be successfully
performed while preserving the function of the overlying
retina by recording focal VEPs in response to visible light, and
we show how corneal potential recordings can be used to
validate device activation. Together these results provide
evidence for the viability of a subretinal nanowire prosthetic
approach to vision restoration.
Measuring VEPs and EEPs in an in vivo animal model is a
standard preclinical practice for most retinal prosthesis
research groups; however, there is considerable variability in
how results are presented due to a lack of standardized
methods. Even so, there are still specific response hallmarks
that are common between groups. For example, although
some groups present a fast positive peak followed by a long
negative trough,26,27,30 whereas other groups present a fast
negative trough followed by a long positive peak,20–22,24,25,28,31
there is still a typical waveform pattern of a short latency
voltage deflection (either negative or positive) followed by a
rapid reversal in voltage that slowly decays back to baseline.
This typical waveform pattern is qualitatively similar to a
classical VEP waveform, with one major difference being that
EEP latencies are generally shorter than VEP latencies.24,27 It is
theorized that the shorter latencies of electrical retinal
stimulation are a result of bypassing the relatively slow
phototransduction cascade of the photoreceptors by directly
stimulating inner retinal neurons. Our results are consistent
with other groups, showing a shorter N1 EEP latency than VEP
N1 and a characteristic waveform that fits the overall
interpretation of EEPs.
Vertical silicon nanowires are highly efficient at using the
photovoltaic effect to convert light into electrical stimulation.
The p-n junction within the silicon photodiode is responsible
for the photovoltaic conversion of light to current; no other
material used in the fabrication of the device can contribute to
the photocurrent given the band gap energies of each
material.32–35 In this study, we used 3.4-mW/mm2 IR light to
activate the silicon nanowires operating in photovoltaic mode.
This level of irradiance is 20 times lower than thermal safety
limits for 10-ms pulses of 852-nm light.38 Past work from our
group has shown that applying bias to the nanowire devices
TABLE. Cortical Potential Amplitude Averages and Experimental Group Comparisons
Experimental condition Focal green VEP Device-elicited EEP IR in nonimplanted eye Baseline activity
Number of recordings n ¼ 45 n ¼ 108 n ¼ 22 n ¼ 54
Cortical potential amplitude Average ¼ 94.88 lV Average ¼ 54.17 lV Average ¼ 24.07 lV Average ¼ 23.22 lV
Standard deviation SD ¼ 43.3 SD ¼ 33.4 SD ¼ 22.1 SD ¼ 17.2
Baseline activity P < 0.0001 P < 0.0001 P ¼ 0.8827
IR in Nonimplanted eye P < 0.0001 P < 0.0001
Device-elicited EEP P < 0.0001
The average VEP elicited by focal green stimulation was significantly higher than all other conditions (column 1). The average EEP elicited by
device activation was significantly higher than both baseline activity and IR in the nonimplanted eye (column 2). IR stimulation of the nonimplanted
eye did not result in cortical activity any greater than baseline cortical activity (column 3).
FIGURE 6. The average focal VEP amplitude (94.88 6 43.3 lV) was
significantly higher than EEP (54.17 6 33.4 lV), IR only (24.07 6 22.1
lV), and baseline cortical activity (23.22 6 17.2 lV) amplitudes.
Average EEP amplitude differed significantly from IR stimulation of the
nonimplanted eye and baseline. Cortical potentials measured when
stimulating the nonimplanted eye with IR light did not generated
amplitudes significantly different from baseline cortical activity. Boxes
indicate 25th/75th percentiles, and dotted lines are the ranges of
amplitude values.
In Vivo Performance of Nanowire Retinal Prosthesis IOVS j December 2018 j Vol. 59 j No. 15 j 5889
greatly increases the gain, which can be exploited to further
decrease the irradiance required to reach stimulation thresh-
old.17 Regardless, these experiments serve as an important
proof of principle in the design of subretinal nanowire
prosthetics. Future experiments will explore the relationship
between light intensity, charge injection, stimulation frequen-
cy, and the stimulation threshold to elicit EEPs.
The corneal potential recorded from the ERG electrode
served as a control to confirm device activation. Corneal
potential increased logarithmically as the IR laser power was
increased, consistent with a logarithmic increase in charge
output. This is congruent with similar work from Lorach et
al., which reported increased corneal potential amplitude
with increased illumination area.20 As expected, the absolute
amplitudes of corneal potentials are not directly comparable
between subjects due to variations in electrode placement,
tissue impedances, or anatomical differences, but relative
potential over a range of irradiance provides a qualitative
measure of device performance.39 The corneal waveform
could also be modulated by decreasing or increasing the laser
pulse duration (data not shown), which can be used as
another measure of validating device performance. Corneal
monitoring of device activation is an important control
measure in clinical testing because it can be noninvasively
used as a method to verify device function over the lifetime of
the implant.
The optically activated nanowire-based prosthesis offers
several significant advantages to other retinal prosthetic
strategies currently being pursued. The nanowire design
allows the integration of photodetection and neural stimula-
tion into each pixel. This allows for individual pixels to be
optically addressed, which greatly simplifies the form factor
and packaging requirements for a retinal prosthesis and
obviates the need for hard wired connections to the pixels of
an external camera,40 which is a daunting engineering
challenge. It also eliminates the need for a complicated
integrated circuit for each pixel as in the case for prosthetics
making use of an intraocular CMOS sensor.41 With the
nanowire-based prosthesis, a large number of high density
electrodes can be placed in a small surgically tractable package.
The device tested here covered approximately a 3-34-mm area
of retina providing more than 178 of visual field while
containing 1512 electrodes at 50-lm spacing. This design
may offer advantages versus the individually wired 60
electrodes in the Argus II or the 378 optically addressed
electrodes in the Pixium PRIMA in terms of electrode density
and visual field and with a simpler electrical component
packaging strategy compared with the Alpha AMS. Although
estimation of visual acuity from retinal spacing alone is
challenging, it is widely assumed that increasing pixel density
will lead to an increase in visual acuity. From sampling theory, a
50-lm pixel pitch roughly corresponds to a best theoretical
acuity of approximately 20/400.42–44 This compares favorably
with other devices on the market or in clinical testing in terms
of array spacing.41,45–47 Taken together the photovoltaic
nanowire device described here represents a novel advance
in the field of retinal prosthetics.
CONCLUSIONS
In this paper, we demonstrated how a passive, unpowered
nanowire photodiode array can transduce light into an
electrical stimulation that evokes a physiologic response in
the rabbit visual cortex. We previously showed ex vivo that we
can further boost the sensitivity of the system by providing bias
power.17 In future experiments, we will harness this effect to
enable phototransduction under dimmer light conditions by
applying external power to the nanowires to increase the
dynamic range of electrical stimulation and reduce the light
intensity required to elicit a response.
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